saascode
project & workflow operations·run 261 · Jun 2026

Filewright

A continuous control-evidence workbench for small regulated professional firms that collects authorized workspace records, maps them to scoped obligations and control claims, routes quarterly review and remediation, and exports a source-linked package without calling evidence presence examiner acceptance or compliance.

Genesis score6.93/10
Make Filewright real.0/500
500 more votes and Filewright is authorized for build.
0%500 to authorize
Backing is the vote. When an idea crosses 500, we pull it into the build pipeline and ship it for real — the votes decide what gets built next, not an editor.
The opportunity
2Cross-references
4Inbound connections
2Direct connections
The case

Small law firms, investment advisers, family offices, and healthcare practices can face recurring policy, access, retention, security, vendor, and supervisory evidence requests without a dedicated governance team. Filewright creates a quarterly evidence cycle over the firm's existing productivity workspace: scoped collection, source lineage, control mapping, reviewer disposition, gap, remediation, management approval, export, and correction. File presence is not control operation, a workspace event is not business meaning, an integrity signature is not completeness, and an exported packet is not examiner acceptance or legal compliance. Requirement, applicability, source record, observation, control claim, reviewer conclusion, management assertion, independent examination, regulator response, and correction remain distinct.

Who pays — and why

An owner, compliance officer, operations leader, security lead, or external adviser serving a regulated professional firm with fewer than fifty people and a recurring evidence burden.

What it unlocks
An applicability and control register preserving regime, entity, jurisdiction, requirement source, effective period, interpretation owner, control statement, responsible person, review cadence, exception, supersession, and correction
An evidence graph linking authorized workspace source, object, actor, time, scope, collection method, immutable original, derived observation, control claim, reviewer, period, retention, access, integrity record, and gap
A recurring review ledger separating requested evidence, collected artifact, mapping candidate, reviewer disposition, remediation, management assertion, package export, recipient acknowledgment, examination finding, response, and correction
How Genesis scored it
6.93across seven criteria
tension 6temporal 8blindspot 6buyer 8leverage 6convergence 5why-not 8
8
Temporal window

A confirmed June 2026 launch validates current continuous-compliance demand, though no universal regulatory deadline is supplied.

8
Buyer persona

Owners and compliance leaders in small regulated firms are specific and face recurring evidence requests.

5
Convergence

Two cross-references, four inbound connections, and two direct connections show repeated demand while the grounded score remains five.

Why it scored well

Two cross-references, four inbound and two direct links, a named small regulated-firm buyer, a confirmed premium continuous-compliance service, available workspace and integrity primitives, and no identified low-cost workspace-native quarterly evidence tool support a clear down-market wedge.

What's holding it back

Applicability differs across professions and jurisdictions, workspace data is incomplete and sensitive, control operation often occurs outside the workspace, examiner expectations vary, integrations and reviewer support are substantial, and the proposed low price and self-service economics are unvalidated.

Signals detected4 sources crossed
SignalCentersky Secure product research

SignalSigstore project research

Signalimmudb project research

SignalSource-run market scan

Direction brieffilewright.md
filewright.md
Want this pointed at your vertical?Point Genesis at your own market and constraints — it invents adjacent, fork-ready ideas, private to you before they hit the public feed.

Discussion

?

No comments yet — be the first to weigh in.